» Articles » PMID: 22092622

Radiographic Heart Size and Its Rate of Increase As Tests for Onset of Congestive Heart Failure in Cavalier King Charles Spaniels with Mitral Valve Regurgitation

Overview
Date 2011 Nov 19
PMID 22092622
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In canine mitral regurgitation (MR) the rate of heart enlargement increases in the last year before congestive heart failure (CHF). Measurement of heart size and its rate of increase may be useful tests for CHF in MR.

Objectives: To determine the value of vertebral heart scale (VHS) and its rate of increase (∆VHS units/month) for diagnosing the presence and predicting the onset of CHF.

Animals: Longitudinal study of 94 Cavalier King Charles Spaniels (CKCS).

Methods: VHS was measured at intervals before CHF. ∆VHS/month was calculated from sequential pairs of VHS measurements and the interval between them. Diagnostic accuracy and utility were determined by the areas under receiver operating characteristic plots (AUROC), and likelihood ratios (LR).

Results: AUROC for VHS at the onset of CHF was 0.93 (95% CI, 0.96-0.90), to predict CHF 1-12 months before CHF was 0.74 (95% CI, 0.81-0.66), and for ∆VHS/month at CHF was 0.98 (95% CI, 0.99-0.96). Interval LRs and their cutoff values for CHF were for VHS: 13 (95% CI, 20-7.3) at ≥12.7; 1.2 (95% CI, 2.0-0.68) between 12.7 and 12.0; 0.04 (95% CI, 0.18-0.01) at ≤12.0, and for ∆VHS/month: 15 (95% CI, 30-7.7) at ≥0.08; 0.72 (95% CI, 2.0-0.25) between 0.08 and 0.06; and 0.05 (95% CI, 0.13-0.02) at ≤0.06.

Conclusions And Clinical Importance: Under the conditions of this study, VHS and particularly ∆VHS/month are useful measurements for detecting onset of CHF in CKCS with MR.

Citing Articles

Vertebral Heart Score and Vertebral Left Atrial Size as Radiographic Measurements for Cardiac Size in Dogs-A Literature Review.

Baisan R, Vulpe V Animals (Basel). 2025; 15(5).

PMID: 40075966 PMC: 11899317. DOI: 10.3390/ani15050683.


Comparison Between Radiographic Vertebral Left Atrial Size (VLAS) and Echocardiographic Methods for Predicting Left Atrial Remodeling in Dogs With Mitral Valve Disease.

Pereira N, Bispo G, Carneiro M, Buzo R, Jane D, Linhares L Vet Med Int. 2025; 2025:5516116.

PMID: 39949612 PMC: 11825196. DOI: 10.1155/vmi/5516116.


Echocardiographic Changes in Dogs with Stage B2 Myxomatous Mitral Valve Disease Treated with Pimobendan Monotherapy.

Crosland A, Cortes-Sanchez P, Sudunagunta S, Bouvard J, Bode E, Culshaw G Vet Sci. 2024; 11(12).

PMID: 39728934 PMC: 11680358. DOI: 10.3390/vetsci11120594.


Radiographic Left Atrial Size Measurement of Dogs in Different Mitral Valve Disease Stages with Four Different Methods.

Marbella Fernandez D, Montoya-Alonso J Animals (Basel). 2023; 13(24).

PMID: 38136872 PMC: 10741156. DOI: 10.3390/ani13243835.


Self-Reported Utilization of International Guidelines for Staging Dogs with Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners.

van Staveren M, Muis E, Szatmari V Vet Sci. 2023; 10(12).

PMID: 38133238 PMC: 10747438. DOI: 10.3390/vetsci10120687.